BRG Borregaard

Borregaard ASA: EBITDA NOK 242 million (NOK 255 million) in the 1st quarter

Borregaard ASA: EBITDA NOK 242 million (NOK 255 million) in the 1st quarter

Borregaard’s operating revenues increased to NOK 1,372 million (NOK 1,250 million)¹ in the 1st quarter of 2020. EBITDA² was NOK 242 million (NOK 255 million). BioSolutions (ligninbased biopolymers and biovanillin) and BioMaterials (speciality cellulose and cellulose fibrils) had results in line with the 1st quarter of 2019, whereas Fine Chemicals (pharma intermediates and bioethanol) had a decline. The Group has not been materially impacted by the coronavirus situation during the 1st quarter of 2020.

BioSolutions had a positive development within Specialities, while both BioMaterials and Fine Chemicals had an unfavourable product mix in the quarter. Operating costs were higher due to increased transatlantic shipments, maintenance and an IT transition project. Wood costs were gradually reduced during the quarter, but less than expected.

The net currency impact on EBITDA² was positive. Towards the end of the 1st quarter, NOK weakened significantly. Borregaard’s sales are primarily in USD and EUR, and a weakening of NOK will over time be positive for the Group’s competitive position. However, at the end of the quarter, the Group’s equity and net interest-bearing debt were negatively affected by unrealised losses from currency hedging, realised effect of hedging of net investments in subsidiaries and translation effects on loans in USD.

Profit before tax was NOK 111 million (NOK 141 million). Earnings per share were NOK 1.02 (NOK 1.26).

-  We are pleased to see a favourable development for Specialities in BioSolutions. So far, the impact from the coronavirus situation has been limited on our business, says President and CEO Per A. Sørlie.

Contacts:

Director Investor Relations, Jørn Syvertsen,  335

Communication Manager, Tone Horvei Bredal,

1. Figures in parentheses are for the corresponding period in the preceding year

2. Operating profit before depreciation, amortisation and other income and expenses

This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Attachments

EN
29/04/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Borregaard

 PRESS RELEASE

Borregaard ASA: Tom Erik Foss-Jacobsen appointed CEO of Borregaard

Borregaard ASA: Tom Erik Foss-Jacobsen appointed CEO of Borregaard Tom Erik Foss-Jacobsen has been appointed CEO of Borregaard ASA. He succeeds Per A. Sørlie, who will retire after 26 years in the position (see notice to Oslo Stock Exchange 3 December 2020). The appointment will be effective 1 August 2025. “I am pleased that Tom Erik Foss-Jacobsen has accepted the position as CEO of Borregaard. With Foss-Jacobsen, Borregaard will get a leader with in-depth understanding of the business and previous experience from significant parts of Borregaard’s international operations. Over several yea...

Niclas Gehin
  • Niclas Gehin

Borregaard (Buy, TP: NOK230.00) - Agricultural products boost Q1 EPS

The solid Q1 results included a 6% EBITDA beat, led by record-high sales and profits from growing agricultural product sales – management said the underlying trend was driven by demand for ‘green’ food production products. Our 2026–2027e EPS are largely unchanged (tweaked by c1%) as the USD depreciation and lowered bioethanol price guidance largely offset the higher agricultural product sales. We still see this as an attractive entry point, and reiterate our BUY and NOK230 target price.

ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Henrik Bartnes
  • Martin Melbye

ResearchPool Subscriptions

Get the most out of your insights

Get in touch